Cargando…
Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/ https://www.ncbi.nlm.nih.gov/pubmed/35167611 http://dx.doi.org/10.1371/journal.pone.0263773 |
_version_ | 1784651866312802304 |
---|---|
author | Wang, Shih-Wei Chan, Leong-Perng Wang, Ling-Feng Wu, Che-Wei Lin, Sheng-Hsuan Huang, Tzu-Yen Lee, Ka-Wo |
author_facet | Wang, Shih-Wei Chan, Leong-Perng Wang, Ling-Feng Wu, Che-Wei Lin, Sheng-Hsuan Huang, Tzu-Yen Lee, Ka-Wo |
author_sort | Wang, Shih-Wei |
collection | PubMed |
description | BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. METHODS: This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992–2003; Group B: 2004–2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. RESULTS: Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. CONCLUSION: Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment. |
format | Online Article Text |
id | pubmed-8846538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88465382022-02-16 Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools Wang, Shih-Wei Chan, Leong-Perng Wang, Ling-Feng Wu, Che-Wei Lin, Sheng-Hsuan Huang, Tzu-Yen Lee, Ka-Wo PLoS One Research Article BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. METHODS: This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992–2003; Group B: 2004–2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. RESULTS: Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. CONCLUSION: Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment. Public Library of Science 2022-02-15 /pmc/articles/PMC8846538/ /pubmed/35167611 http://dx.doi.org/10.1371/journal.pone.0263773 Text en © 2022 Wang et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Wang, Shih-Wei Chan, Leong-Perng Wang, Ling-Feng Wu, Che-Wei Lin, Sheng-Hsuan Huang, Tzu-Yen Lee, Ka-Wo Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title | Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title_full | Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title_fullStr | Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title_full_unstemmed | Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title_short | Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
title_sort | secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/ https://www.ncbi.nlm.nih.gov/pubmed/35167611 http://dx.doi.org/10.1371/journal.pone.0263773 |
work_keys_str_mv | AT wangshihwei secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT chanleongperng secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT wanglingfeng secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT wuchewei secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT linshenghsuan secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT huangtzuyen secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools AT leekawo secondaryprimarymalignancyinpatientswithheadandnecksquamouscellcarcinoma27yearexperiencefromtheperspectiveofdiagnostictools |